Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

64.18
BATS BZX Real-Time Price
As of 11:07am ET
 -0.14 / -0.22%
Today’s Change
45.45
Today|||52-Week Range
71.51
+8.34%
Year-to-Date
AbbVie (ABBV) Q2 Earnings: Will the Stock Pull a Surprise?
10:49am / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen
Jul 21 / Zacks.com - Paid Partner Content
An Investing Overview of the Multiple Sclerosis Market
8:23am / MotleyFool.com - Paid Partner Content
These 5 Healthcare Stocks Have Huge Dividend Yields -- Are Any Worth Buying?
Jul 21 / MotleyFool.com - Paid Partner Content
7 Key Figures From Gilead Sciences' Q2 Earnings
Jul 25 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug
Jul 20 / Zacks.com - Paid Partner Content
Roche (RHHBY) Misses on Q2 Revenues, New Launches in Focus
Jul 25 / Zacks.com - Paid Partner Content
Is This Gilead Sciences' Most Underappreciated Drug Candidate?
Jul 18 / MotleyFool.com - Paid Partner Content
5 Incredibly Cheap Big Pharma Stocks
Jul 25 / MotleyFool.com - Paid Partner Content
3 Big Pharma Stocks That Could Raise Their Dividends
Jul 14 / MotleyFool.com - Paid Partner Content
5 Reasons Biotech Stocks Are Smart Investments
Jul 24 / MotleyFool.com - Paid Partner Content
3 Dividend Aristocrats to Avoid
Jul 14 / MotleyFool.com - Paid Partner Content
3 Important Takeaways From Johnson & Johnson's Second-Quarter Earnings
Jul 24 / MotleyFool.com - Paid Partner Content
Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan
Jul 14 / Zacks.com - Paid Partner Content
Biogen Inc: How Double-Digit Growth Got Trumped
Jul 22 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Juno, Amgen, AbbVie, Gilead and CytRx
Jul 14 / Zacks.com - Paid Partner Content
3 Healthcare ETFs to Buy as JNJ Beats Q2 Earnings
Jul 21 / Zacks.com - Paid Partner Content
Biosimilars set topple two of the world's biggest drug franchises
Jul 14 / FT.com - Paid Partner Content
3 Stocks Driving The Drugs Industry Higher
Jul 21 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Juno In and Out of Clinical Hold, Amgen Biosimilar Gets Panel ...
Jul 13 / Zacks.com - Paid Partner Content
Here's Why Myriad Genetics Is Down 26% in 2016
Jul 21 / MotleyFool.com - Paid Partner Content
AbbVie's ABT-414 Gets Rare Pediatric Disease Status in U.S.
Jul 12 / Zacks.com - Paid Partner Content